Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

Doxorubicin polyisohexylcyanoacrylate nanoparticles

EU orphan designation number: EU/3/04/229   
Active ingredient: Doxorubicin polyisohexylcyanoacrylate nanoparticles
Indication: Treatment of the hepatocellular carcinoma
Sponsor: Onxeo
49 boulevard du Général Martial Valin, 75015 Paris, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
25/10/2004 Orphan designation EMEA/OD/048/04 (2004)4226 of 21/10/2004
20/01/2009 Change of name and/or address of sponsor
24/10/2014 Change of name and/or address of sponsor